• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E-Volve:通过蛋白质界面化学相互作用模式了解 SARS-CoV-2 变体刺突蛋白突变对抗体和 ACE2 亲和力的影响。

E-Volve: understanding the impact of mutations in SARS-CoV-2 variants spike protein on antibodies and ACE2 affinity through patterns of chemical interactions at protein interfaces.

机构信息

Laboratory of Bioinformatics and Systems, Institute of Exact Sciences, Department of Computer Science, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

Laboratory of Quantum and Computational Chemistry, Center of Exact and Natural Sciences, Department of Chemistry, Universidade Federal da Paraíba, João Pessoa, PB, Brazil.

出版信息

PeerJ. 2022 Mar 22;10:e13099. doi: 10.7717/peerj.13099. eCollection 2022.

DOI:10.7717/peerj.13099
PMID:35341044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8953562/
Abstract

BACKGROUND

The SARS-CoV-2 pandemic reverberated, posing health and social hygiene obstacles throughout the globe. Mutant lineages of the virus have concerned scientists because of convergent amino acid alterations, mainly on the viral spike protein. Studies have shown that mutants have diminished activity of neutralizing antibodies and enhanced affinity with its human cell receptor, the ACE2 protein.

METHODS

Hence, for real-time measuring of the impacts caused by variant strains in such complexes, we implemented E-Volve, a tool designed to model a structure with a list of mutations requested by users and return analyses of the variant protein. As a proof of concept, we scrutinized the spike-antibody and spike-ACE2 complexes formed in the variants of concern, B.1.1.7 (Alpha), B.1.351 (Beta), and P.1 (Gamma), by using contact maps depicting the interactions made amid them, along with heat maps to quantify these major interactions.

RESULTS

The results found in this study depict the highly frequent interface changes made by the entire set of mutations, mainly conducted by N501Y and E484K. In the spike-Antibody complex, we have noticed alterations concerning electrostatic surface complementarity, breaching essential sites in the P17 and BD-368-2 antibodies. Alongside, the spike-ACE2 complex has presented new hydrophobic bonds.

DISCUSSION

Molecular dynamics simulations followed by Poisson-Boltzmann calculations corroborate the higher complementarity to the receptor and lower to the antibodies for the K417T/E484K/N501Y (Gamma) mutant compared to the wild-type strain, as pointed by E-Volve, as well as an intensification of this effect by changes at the protein conformational equilibrium in solution. A local disorder of the loop α1'/β1', as well its possible effects on the affinity to the BD-368-2 antibody were also incorporated to the final conclusions after this analysis. Moreover, E-Volve can depict the main alterations in important biological structures, as shown in the SARS-CoV-2 complexes, marking a major step in the real-time tracking of the virus mutant lineages. E-Volve is available at http://bioinfo.dcc.ufmg.br/evolve.

摘要

背景

SARS-CoV-2 大流行引起了全球范围的健康和社会卫生问题。病毒的突变株引起了科学家的关注,因为它们在病毒刺突蛋白上存在趋同的氨基酸变化。研究表明,突变株的中和抗体活性降低,与病毒的人类细胞受体 ACE2 蛋白的亲和力增强。

方法

因此,为了实时测量变异株在这些复合物中引起的影响,我们开发了 E-Volve,这是一种设计用于对用户请求的突变列表建模并返回变异蛋白分析的工具。作为概念验证,我们使用接触图描绘了它们之间的相互作用,并使用热图量化了这些主要相互作用,仔细研究了在关注的变异株 B.1.1.7(阿尔法)、B.1.351(贝塔)和 P.1(伽马)中形成的刺突-抗体和刺突-ACE2 复合物。

结果

本研究发现的结果描绘了整个突变集引起的高度频繁的界面变化,主要由 N501Y 和 E484K 引起。在刺突-抗体复合物中,我们注意到与静电表面互补性有关的变化,破坏了 P17 和 BD-368-2 抗体的关键部位。同时,刺突-ACE2 复合物出现了新的疏水键。

讨论

泊松-玻尔兹曼计算的分子动力学模拟证实了 E-Volve 指出的 K417T/E484K/N501Y(伽马)突变体与野生型相比对受体的互补性更高,对抗体的互补性更低,以及在溶液中蛋白质构象平衡变化的情况下,这种效应的增强。分析后,还将α1'/β1'环的局部无序及其对 BD-368-2 抗体亲和力的可能影响纳入最终结论。此外,E-Volve 可以描绘 SARS-CoV-2 复合物等重要生物结构的主要变化,这标志着实时跟踪病毒突变株的重要一步。E-Volve 可在 http://bioinfo.dcc.ufmg.br/evolve 获得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/1831ed0738a1/peerj-10-13099-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/855396c062fe/peerj-10-13099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/38796b374e40/peerj-10-13099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/31132f35c4fe/peerj-10-13099-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/dc205d51b9ff/peerj-10-13099-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/5036f7365fbd/peerj-10-13099-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/a126f8ba48e3/peerj-10-13099-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/1831ed0738a1/peerj-10-13099-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/855396c062fe/peerj-10-13099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/38796b374e40/peerj-10-13099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/31132f35c4fe/peerj-10-13099-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/dc205d51b9ff/peerj-10-13099-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/5036f7365fbd/peerj-10-13099-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/a126f8ba48e3/peerj-10-13099-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e949/8953562/1831ed0738a1/peerj-10-13099-g007.jpg

相似文献

1
E-Volve: understanding the impact of mutations in SARS-CoV-2 variants spike protein on antibodies and ACE2 affinity through patterns of chemical interactions at protein interfaces.E-Volve:通过蛋白质界面化学相互作用模式了解 SARS-CoV-2 变体刺突蛋白突变对抗体和 ACE2 亲和力的影响。
PeerJ. 2022 Mar 22;10:e13099. doi: 10.7717/peerj.13099. eCollection 2022.
2
Understanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2).解析 SARS-CoV-2 刺突突变体与 ACE2(血管紧张素转化酶 2)的分子相互作用。
J Biomol Struct Dyn. 2022;40(23):12760-12771. doi: 10.1080/07391102.2021.1975569. Epub 2021 Sep 8.
3
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.常见突变对 SARS-CoV-2 刺突 RBD 及其配体人 ACE2 受体结合亲和力和动力学的影响。
Elife. 2021 Aug 26;10:e70658. doi: 10.7554/eLife.70658.
4
Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility.SARS-CoV-2 刺突蛋白/人 ACE2 复合物界面的结构建模可以识别与传播性增加相关的高亲和力变体。
J Mol Biol. 2021 Jul 23;433(15):167051. doi: 10.1016/j.jmb.2021.167051. Epub 2021 May 14.
5
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
6
Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.在下午3点的情境下,对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白/血管紧张素转换酶2(ACE2)蛋白质-蛋白质相互作用进行建模,以预测新的刺突蛋白变体与ACE2以及与ACE2结构相关的新型人类蛋白质靶点的结合亲和力,用于新冠疫情应对。
EPMA J. 2022 Jan 6;13(1):149-175. doi: 10.1007/s13167-021-00267-w. eCollection 2022 Mar.
7
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.针对关注的 SARS-CoV-2 变体的中和抗体的表位分类和 RBD 结合特性。
Front Immunol. 2021 Jun 4;12:691715. doi: 10.3389/fimmu.2021.691715. eCollection 2021.
8
Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.计算分解揭示了表达 N501Y 突变的 SARS-CoV-2-ACE2 界面在病毒变异体中的重塑。
J Cell Biochem. 2021 Dec;122(12):1863-1872. doi: 10.1002/jcb.30142. Epub 2021 Sep 13.
9
In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.利用计算机模拟方法研究新型英国(B.1.1.7)和南非(501Y.V2)SARS-CoV-2 变异株,重点关注 ACE2-刺突 RBD 界面。
Int J Mol Sci. 2021 Feb 8;22(4):1695. doi: 10.3390/ijms22041695.
10
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.GB-2阻断ACE2与新型冠状病毒野生型及刺突蛋白突变体之间的相互作用。
Biomed Pharmacother. 2021 Oct;142:112011. doi: 10.1016/j.biopha.2021.112011. Epub 2021 Aug 5.

引用本文的文献

1
COC DA - a fast and scalable algorithm for interatomic contact detection in proteins using C distance matrices.COC DA——一种使用C距离矩阵在蛋白质中进行原子间接触检测的快速且可扩展的算法。
Front Bioinform. 2025 Sep 1;5:1630078. doi: 10.3389/fbinf.2025.1630078. eCollection 2025.
2
Binding affinity between coronavirus spike protein and human ACE2 receptor.冠状病毒刺突蛋白与人ACE2受体之间的结合亲和力。
Comput Struct Biotechnol J. 2024 Jan 17;23:759-770. doi: 10.1016/j.csbj.2024.01.009. eCollection 2024 Dec.

本文引用的文献

1
VTR: A Web Tool for Identifying Analogous Contacts on Protein Structures and Their Complexes.VTR:一种用于识别蛋白质结构及其复合物上类似接触点的网络工具。
Front Bioinform. 2021 Nov 8;1:730350. doi: 10.3389/fbinf.2021.730350. eCollection 2021.
2
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.新冠病毒德尔塔变异株引发的大型溯源清晰的暴发中的病毒感染和传播。
Nat Commun. 2022 Jan 24;13(1):460. doi: 10.1038/s41467-022-28089-y.
3
Featuring ACE2 binding SARS-CoV and SARS-CoV-2 through a conserved evolutionary pattern of amino acid residues.
通过氨基酸残基保守进化模式,SARS-CoV 和 SARS-CoV-2 均具有 ACE2 结合作用。
J Biomol Struct Dyn. 2022;40(22):11719-11728. doi: 10.1080/07391102.2021.1965028. Epub 2021 Sep 6.
4
N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2.SARS-CoV-2 刺突蛋白的 N501Y 突变增强了其与受体 ACE2 的结合。
Elife. 2021 Aug 20;10:e69091. doi: 10.7554/eLife.69091.
5
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2(德尔塔)变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
6
Delta coronavirus variant: scientists brace for impact.德尔塔冠状病毒变种:科学家们严阵以待。
Nature. 2021 Jul;595(7865):17-18. doi: 10.1038/d41586-021-01696-3.
7
A higher flexibility at the SARS-CoV-2 main protease active site compared to SARS-CoV and its potentialities for new inhibitor virtual screening targeting multi-conformers.与 SARS-CoV 相比,SARS-CoV-2 主蛋白酶活性位点的灵活性更高,以及针对多构象体的新型抑制剂虚拟筛选的潜力。
J Biomol Struct Dyn. 2022;40(19):9214-9234. doi: 10.1080/07391102.2021.1924271. Epub 2021 May 10.
8
Antibody evasion by the P.1 strain of SARS-CoV-2.SARS-CoV-2 P.1 株的抗体逃逸。
Cell. 2021 May 27;184(11):2939-2954.e9. doi: 10.1016/j.cell.2021.03.055. Epub 2021 Mar 30.
9
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白E484K突变降低抗体中和作用。
Lancet Microbe. 2021 Jul;2(7):e283-e284. doi: 10.1016/S2666-5247(21)00068-9. Epub 2021 Apr 7.
10
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.逃避单克隆抗体LY-CoV555及其与LY-CoV016的鸡尾酒疗法的SARS-CoV-2受体结合域突变的完整图谱。
Cell Rep Med. 2021 Apr 20;2(4):100255. doi: 10.1016/j.xcrm.2021.100255. Epub 2021 Apr 5.